×
Enjoying ad-free content?
Since July 1, 2024, we have disabled all ads to improve your reading experience.
This commitment costs us $10,000 a month. Your support can help us fill the gap.
Support us
Our journalism is banned in Russia. We need your help to keep providing you with the truth.

Tarnow Gets Tactical

Poland's top chemicals maker, Azoty Tarnow, said Friday that it would seek shareholder backing for a giant share issue as it sets up defenses against a $440 million unsolicited offer by Acron.

Azoty will ask its shareholders, including the Polish state, which holds a 32 percent stake, to give it the option to raise the share capital by up to 75 percent within three years, which would water down existing shareholders.

An extraordinary shareholder meeting for a vote on the plan is scheduled for July 14. Investors will need to register their shares by June 28, a day before Acron's extended bid ends, meaning the Russian bidder will not be able to vote.

(Reuters)

A Message from The Moscow Times:

Dear readers,

We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."

These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.

We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.

By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more